Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.47 |
| ▸ | EGLN1 | Q9GZT9 | 4/20 | 0.46 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.46 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.46 |
| ▸ | CTSA | P10619 | 1/20 | 0.40 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.39 |
| ▸ | SHMT2 | P34897 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.37 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.37 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.37 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.37 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.36 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17892017 | 1.00 | KDM4C (0.47) | KDM4CEGLN1BBOX1FTOCTSA | |
| SCHEMBL20876090 | 1.00 | KDM4C (0.47) | KDM4CEGLN1BBOX1FTOCTSA | |
| SCHEMBL21914754 | 1.00 | KDM4C (0.47) | KDM4CEGLN1BBOX1FTOCTSA | |
| SCHEMBL30473365 | 0.89 | MEN1 (0.41) | CTSASMN1; SMN2TAS1R3TAS1R1ALDH1A1 | |
| SCHEMBL20892686 | 0.89 | MEN1 (0.41) | CTSASMN1; SMN2TAS1R3TAS1R1ALDH1A1 | |
| SCHEMBL26430243 | 0.89 | CTSA (0.37) | KDM4CEGLN1BBOX1FTOCTSA | |
| SCHEMBL20886342 | 0.89 | CTSA (0.37) | KDM4CEGLN1BBOX1FTOCTSA | |
| SCHEMBL26430148 | 0.89 | CTSA (0.37) | KDM4CEGLN1BBOX1FTOCTSA | |
| SCHEMBL20886341 | 0.88 | CTSA (0.37) | KDM4CEGLN1BBOX1FTOCTSA | |
| SCHEMBL19897488 | 0.88 | KDM4C (0.40) | KDM4CEGLN1BBOX1FTOCTSA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3710429-B1 | MICROBIOCIDAL PICOLINAMIDE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2023-04-05 | — | — | EP | disclosed |
| US-11291205-B2 | Microbiocidal picolinamide derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2022-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11291205-B2 | Microbiocidal picolinamide derivatives | CASP2, CASP1, MSR1 | KDM4C 4224/4885EGLN1 1146/4885BBOX1 1049/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.